Urinary hexane diamine to assess respiratory exposure to hexamethylene diisocyanate aerosol: A human inhalation study

International Journal of Occupational and Environmental Health

Volumn 10, Issue 3, 2004, Pages 262-271

  Liu, Youcheng ^a   Berode, Michele ^b   Stowe, Meredith H ^a   Holm, Carole T ^a   Walsh, Frank X ^a   Slade, Martin D ^a   Boeniger, Mark F ^c   Redlich, Carrie A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Biological monitoring; Biomarkers; Exposure assessment; Hexamethylene diisocyanate (HDI); Hexane diamine (HDA); SPRAY

Indexed keywords

BIOLOGICAL MARKER; CREATININE; DIAMINE; HEXAMETHYLENE DIISOCYANATE; HEXANE; HEXANEDIAMINE; UNCLASSIFIED DRUG;

ADULT; AEROSOL; AGED; ARTICLE; EVALUATION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INHALATION; MALE; MASS SPECTROMETRY; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESPIRATORY SYSTEM; URINE LEVEL; WORKPLACE;

EID: 4444250226     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/oeh.2004.10.3.262     Document Type: Article

References (34)

1. Tarlo SM, Banks D, Liss G, Broder I. Outcome determinants for isocyanate induced occupational asthma among compensation claimants. Occup Environ Med. 1997;54:756-61.
2. Streicher RP, Reh CM, Key-Schwartz RJ, Schlecht PC, Cassinelli ME, O'Connor PF. Selecting isocyanate sampling and analytical methods. Appl Occup Environ Hyg. 2002;17:157-62.
3. Janko M, McCarthy K, Fajer M, Raalte JV. Occupational exposure to 1,6-hexamethylene diisocyanKte-based polyisocyanates in the State of Oregon, 1980-1990. Am Ind Hyg Assoc J. 1992; 53:331-8.
4. Williams NR, Jones K, Cocker J. Biological monitoring to assess exposures from use of isocyanates in motor vehicle repair. Occup Environ Med. 1999;56:598-601.
5. Huynh CK, Vu-Duc T, Savolainen H. Design and evaluation of a solid sampler for the monitoring of airborne 1,6-hexamethylene diisocyanate (HDI) and its prepolymers in two-component spray painting. Am Ind Hyg Assoc J. 1992;53:157-62.
6. Vandenplas O, Cartier A, Lesage J, et al. Prepolymers of hexamethylene diisocyanate as a cause of occupational asthma. J Allergy Clin Immunol. 1993;91:850-61.
7. Malo JL, Ouimet G, Cartier A, Levitz D, Zeiss CR. Combined alveolitis and asthma due to hexamethylene diisocyanate (HDI), with demonstration of crossed respiratory and immunologic reactivities to diphenylmethylene diisocyanate (MDI). J Allergy Clin Immunol. 1983;72:413-9.
8. Seguin P, Allard A, Cartier A, Malo JL. Prevalence of occupational asthma in spray painters exposed to several types of isocyanates, including polymethylene polyphenylisocyanates. J Occup Med. 1987;29:340-4.
9. Piirila PL, Nordman H, Keskinen HM, et al. Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma. Am J Respir Crit Care Med. 2000;162:516-22.
10. Sumi Y, Kyi M, Miyazaki Y, Ohtani Y, Miyake S, Yoshizawa Y. Cytokine mRNA expression in isocyanate-induced hypersensitivity pneumonitis. Respiration. 2003;70(3):284-91.
11. Streicher RP, Reh CM, Key-Schwartz RJ, Schlecht PC, Cassinelli ME, O'Connor PF. Determination of airborne isocyanate exposure: considerations in method selection. Am Ind Hyg Assoc J. 2000;61:544-56.
12. Redlich CA, Stowe MH, Wisnewski AV, et al. Subclinical immunologic and physiologic responses in hexamethylene diisocyanate-exposed auto body shop workers. Am J Ind Med. 2001;39:587-97.
13. Health and Safety Executive. MDHS 25: Method for the determination of hazardous substances: organic isocyanates in air. London, England: Health and Safety Executive/Occupational Safety and Hygiene Laboratory, 1987.
14. National Institute for Occupational Safety and Health (NIOSH). Method 5522: Isocyanates. I:n Eller PM (ed). NIOSH Manual of Analytical Methods. 4th ed. 1st suppl. DHHS/ NIOSH pub. No. 94-113. Cincinnati, OH: NIOSH, 1996.
15. Bello D, Streicher RP, Woskie SR. Evaluation of the NIOSH draft method 5525 for determination of the total reactive isocyanate group (TRIG) for aliphatic isocyanates in auto body repair shops. J Environ Monit. 2002;4:351-60.
16. Occupational Safety and Health Administration (OSHA). Method 42: Diisocyanates: Toluene-2,6-Diisocyanate (2,6-TDI), 1,6-Hexamethylene Diisocyanate (HDI), and Toluene-2,4-Diisocyanate. Salt Lake City, UT: OSHA, 1983.
17. Maître A, Berode B, Perdrix A, Romazini S, Savolainen H. Biological monitoring of occupational exposure to toluene diisocyanate. Int Arch Occup Environ Health. 1993;65:97-100.
18. Dalene M, Skarping G, Brorson T. Chromatographic determination of amines in biological fluids with special reference to the biological monitoring of isocyanates and amines. IV. Determination of 1,6-hexamethylenediamine in human urine using capillary gas chromatography and selective iron monitoring. J Chromatogr. 1990;516:405-13.
19. Dalene M, Skarping G, Tinnerberg H. The biological monitoring of 1,6-hexamethylene diisocyanate using capillary gas chromatography with thermionic and selective iron monitoring. J Chromatogr B Biomed Appl. 1994;656:319-28.
20. Rosenberg C, Savolainen H. Determination in urine of diisocyanate-derived amines from occupational exposure by gas chromatography-mass fragmentography. Analyst. 1986;111: 1069-71.
21. Brorson T, Skarping G, Sandstrom JF, Stenberg M. Biological monitoring of isocyanates and related amines. I. Determination of 1,6-hexamethylenediamine (HDA) in hydrolysed human urine after oral administration of HDA. Int Arch Occup Environ Health. 1990;62:79-84.
22. Brorson T, Skarping G, Nielsen J. Biological monitoring of socyanates and related amines. II. Test chamber exposure of humans exposed to 1,6-hexamethylene diamine as the trifluoroethyl chloroformate derivative. Int Arch Occup Environ Health. 1990;62:385-9.
23. Maître A, Berode M, Perdrix A, Stoklov M, Mallion JM, Savolainen H. Urinary hexane diamine as an indicator of occupational exposure to hexamethylene diisocyanate. Int Arch Occup Environ Health. 1996;69:65-8.
24. Berode M, Testa B, Savolainen H. Bicarbonate-catalyzed hydrolysis of hexamethylene diisocyanate to 1,6-diaminohexane. Toxicol Lett. 1991;56:173-8.
25. Cloutier Y. Device for specific inhalation challenge, method of use and improved generator of particles. US Patent Number 5,320,108. Arlington, VA: U.S. Patent and Trade Mark Office, 1994.
26. Vandenplas O, Malo JC, Cartier A, Perrault G, Cloutier Y Closed-circuit methodology for inhalation challenge tests with isocynnates. Am Rev Respir Dis. 1992;145:582-7.
27. Sterk PJ, Plomp A, van de Rate JF, Quanjer PH. Physical properties of aerosol produced by several jet-and ultrasonic nebulizers. Bull Eur Physiopathol Respir. 1984;20:65-72.
28. ATS. Standardization of spirometry. Am J Respir Criti Med. 1995;152:1107-36.
29. ASTM. Standard test method for determination of aerosol monomeric and oligomeric hexamethylene diisocyanate (HD1) in air with (methoxy-2-phenyl-1) piperazine (MOPIP) in the workplace. ASTM Designation D6561-00. 2002;1-5.
30. ASTM. Standard test method for determination of gaseous hexamethylene diisocyanate (HD1) in air with 9-(N-methylaminomethyl) anthracene method (MAMA) in the workplace. ASTM Designation D6562-00. 2002;1-6.
31. Bello D, Woskie SR, Redlich CA, et al. Polyisocyanates in occupational environments: a critical review of exposure limits and metrics. Am J Ind Med. In press.
32. Crowley-Weber CL, Dvorakova K, Crowley C, et al. Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis. Chemico-Biological Interactions. 2003; 145:53-66.
33. Tricker AR. Nicotine metabolism, human drug metabolism polymorphisms, and smoking behavior. Toxicology. 2003; 183:151-73.
34. Kelada SN, Kardia SL, Walker AH, Wein AJ, Malkowicz SB, Rebbeck TR. The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol Biomark Prev. 2000;9:1329-34.